KJHP
ONC

K.J. Harrison & Partners’s BeOne Medicines Ltd ONC Stock Holding History

K.J. Harrison & Partners’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1,200
Closed -$207K – 197
2018
Q3 		$207K Buy
+1,200
New +$202K 0.05% 177

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
HIM
Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

K.J. Harrison & Partners's ONC Position: Q4 2018 in Review

K.J. Harrison & Partners sold out of BeOne Medicines Ltd (ONC) in Q4 2018, closing a stake of 1,200 shares — an estimated $207K sold.

K.J. Harrison & Partners first reported a position in ONC in Q3 2018 and held it in 1 quarter. The position peaked at $207K in Q3 2018. 192 funds tracked by Wall St. Rank hold ONC as of Q4 2018.

  • K.J. Harrison & Partners reported no remaining BeOne Medicines Ltd position as of Q4 2018 after selling out during the quarter.
  • K.J. Harrison & Partners sold 1,200 BeOne Medicines Ltd shares in Q4 2018, an estimated $207K.
  • K.J. Harrison & Partners first reported a position in BeOne Medicines Ltd in Q3 2018 and held it in 1 quarter.
  • K.J. Harrison & Partners's BeOne Medicines Ltd position peaked at $207K in Q3 2018.
  • 192 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q4 2018.

Based on K.J. Harrison & Partners's 13F filing for Q4 2018, filed 24 Jan 2019.